ESG and intangibles: driving value creation across companies - AXA Investment Managers

This paper uses empirical research to show how material ESG factors – as defined by the Sustainability Accounting Standards Board (SASB) – are positively linked to the price-to-book ratio of companies in the global pharmaceutical industry.

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

... To read the full article by Yo Takatsuki, Head of ESG Research and Active Ownership at AXA Investment Managers, and Ryohei Yanagi, Chief Financial Officer Eisai Co Ltd and Visiting Professor, Waseda University, please click on the button below. 

Learn more here